Nexium Judge Gives Rare Look Into Landmark Antitrust Trial

By Melissa Lipman ( July 30, 2015, 9:26 PM EDT) -- U. S. District Judge William G. Young, who last year oversaw the first trial of a pay-for-delay case since the U. S. Supreme Court concluded that pharmaceutical patent settlements could face antitrust challenges, offered a rare window Thursday into his thinking throughout the case as he refused to grant Nexium buyers another jury trial to try to make their case stick. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login